We show here that CRLF2 over-expression has a prognostic impact in T-ALL, with CRLF2-high patients having a significantly inferior EFS and Survival and a higher CIR compared to CRLF2-low patients. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.